<DOC>
	<DOCNO>NCT00100386</DOCNO>
	<brief_summary>Primary Outcome Measures : Incidence density colonization MRSA VRE ( number new colonization event per 1000 patient day risk ) intervention phase . Secondary Outcome Measures : The effect 2 strategy incidence density colonization MRSA VRE individually determine compare descriptively . The effect strategies cumulative incidence bacteremia cause MRSA VRE determine assess clinical relevance strategy prevent infection . The trial evaluate frequency hand hygiene use gloves gown healthcare worker substantiate whether effect intensive control strategy mediate , expect , increase use glove gown due increase number patient care use Contact Precautions .</brief_summary>
	<brief_title>Strategies Reduce Transmission Antimicrobial Resistant Bacteria Intensive Care Units ( STAR*ICU ) Trial</brief_title>
	<detailed_description>This study determine rate colonization infection 2 resistant Gram positive bacteria-methicillin resistant Staphylococcus aureus ( MRSA ) vancomycin resistant enterococci ( VRE ) among patient adult intensive care unit ( ICUs ) low ICUs use intensive infection control strategy plus standard care compare ICUs use standard care alone . The intensive control strategy involve : 1 ) identifying patient colonize MRSA VRE report result surveillance culture anterior naris stool perianal area ; 2 ) Universal Gloving ( use glove interaction patient patient 's environment ) patient discharge surveillance culture result show colonized MRSA VRE ( whichever happen first ) ; 3 ) Contact Precautions ( use glove gown interaction patient patient 's environment ) care patient colonize MRSA VRE . Standard care involve proper hand hygiene ( handwash use waterless hand antiseptic ) use Standard Precautions ( use gloves barrier need interaction involve contact mucous membrane , wound , body fluid ) collection surveillance culture , report result site . The surveillance culture perform obtain swab nose stool perianal area patient upon admission ICU , weekly interval thereafter , upon discharge ICU . The result surveillance culture use compare rate colonization MRSA VRE ICUs use intensive control strategy use standard care alone .</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>ICUs meet follow criterion eligible participate study : 1 . Adult medical , surgical , medical/surgical ICU , meet follow description : Medical ICU &gt; =80 % patient medical condition undergone surgical procedure hospital stay ( patient wean mechanical ventilation may include ) ; Surgical ICU &gt; =80 % patient undergone surgical procedure hospital stay ( thoracic , cardiovascular , abdominal , orthopedic , neurosurgical , transplant , urologic , trauma surgery procedure may include ) ; Medical/surgical ICUa roughly equivalent mixture patient medical condition undergone surgical procedure patient undergone surgical procedure hospitalization ( i.e. , group constitute 20 % le 80 % total number patient ) . 2 . Patient volume &gt; =1200 patient days/6 month &gt; =2400 patient days/12 month 2002 , 2003 , 2004 ; 3 . Incidence density colonization &gt; =9 colonization event either MRSA VRE/1000 ICU patient day base result clinical culture 2002 , 2003 , 2004 ; 4 . Ability collect data require analysis ; 5 . Written approval study institution 's IRB ; 6 . Signed protocol signature page indicate willingness enroll ICU study ICU physician ICU nursing director . Intensive care unit meet follow criterion exclude study : 1 . Coronary care , burn , bone marrow/hematopoetic stem cell transplant , neurosurgical , pediatric , neonatal ICUs ; 2 . ICUs currently screen patient colonization MRSA VRE admission ICU least week ICU stay result surveillance culture report clinician ( Note : ICUs screen select , `` highrisk '' patient , screen patient admission ICU ongoing basis , screen patient MRSA VRE MRSA VRE exclude ) ; 3 . ICUs currently policy Universal Gloving patient contact regardless whether patient know colonized VRE MRSA ; 4 . ICUs plan enroll subject study test investigational agent administer purpose eradicate prevent colonization MRSA VRE device practice management strategy colonization and/or infection resistant organisms outcome .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Hand hygiene , antibiotic resistance , contact precaution</keyword>
</DOC>